AAAAAA
Results:
1-19
|
Results: 19
Authors:
MADER RM
MULLER M
STEGER GG
Citation: Rm. Mader et al., RESISTANCE TO 5-FLUOROURACIL, General pharmacology, 31(5), 1998, pp. 661-666
Authors:
MULLER M
BRUNNER M
SCHMID R
MADER RM
BOCKENHEIMER J
STEGER GG
STEINER B
EICHLER HG
BLOCHLDAUM B
Citation: M. Muller et al., INTERSTITIAL METHOTREXATE KINETICS IN PRIMARY BREAST-CANCER LESIONS, Cancer research, 58(14), 1998, pp. 2982-2985
Authors:
SEDIVY R
MADER RM
Citation: R. Sedivy et Rm. Mader, FRACTALS, CHAOS, AND CANCER - DO THEY COINCIDE, Cancer investigation, 15(6), 1997, pp. 601-607
Authors:
STEGER GG
GNANT MF
DJAVANMARD MP
MADER RM
JAKESZ R
PIERCE W
DEKERNION JB
FIGLIN R
BELLDEGRUN A
Citation: Gg. Steger et al., THE IN-VITRO EFFECTS OF INTERLEUKIN-12 UPON TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM RENAL-CELL CARCINOMA, Journal of cancer research and clinical oncology, 123(6), 1997, pp. 317-324
Authors:
MULLER M
MADER RM
STEINER B
STEGER GG
JANSEN B
GNANT M
HELBICH T
JAKESZ R
EICHLER HG
BLOCHLDAUM B
Citation: M. Muller et al., 5-FLUOROURACIL KINETICS IN THE INTERSTITIAL TUMOR SPACE - CLINICAL-RESPONSE IN BREAST-CANCER PATIENTS, Cancer research, 57(13), 1997, pp. 2598-2601
Authors:
MADER RM
SIEDER AE
BRAUN J
RIZOVSKI B
KALIPCIYAN M
MUELLER MW
JAKESZ R
RAINER H
STEGER GG
Citation: Rm. Mader et al., TRANSCRIPTION AND ACTIVITY OF 5-FLUOROURACIL CONVERTING ENZYMES IN FLUOROPYRIMIDINE RESISTANCE IN COLON-CANCER IN-VITRO, Biochemical pharmacology, 54(11), 1997, pp. 1233-1242
Authors:
FINDENIG G
MADER RM
FRITZERSZEKERES M
STEGER GG
JAEGER W
SZEKERES T
Citation: G. Findenig et al., MODULATION OF 5-FLUOROURACIL RESISTANCE IN HUMAN COLON-TUMOR CELL-LINES BY AZIDOTHYMIDINE, Oncology research, 8(5), 1996, pp. 189-196
Authors:
MADER RM
RIZOVSKI B
STEGER GG
WACHTER A
KOTZ R
RAINER H
Citation: Rm. Mader et al., EXPOSURE OF ONCOLOGIC NURSES TO METHOTREXATE IN THE TREATMENT OF OSTEOSARCOMA, Archives of environmental health, 51(4), 1996, pp. 310-314
Authors:
MADER RM
ZILG H
SCHLAPPACK O
STEGER GG
BAUR M
GREIFENBERG B
HEBERLE U
DITTRICH C
Citation: Rm. Mader et al., PHARMACOKINETICS OF 4'O-TETRAHYDROPYRANYLADRIAMYCIN GIVEN ON A WEEKLYSCHEDULE IN PATIENTS WITH ADVANCED BREAST-CANCER, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 91-96
Authors:
MADER RM
STEGER GG
RIZOVSKI B
DJAVANMARD MP
SCHEITHAUER W
JAKESZ R
RAINER H
Citation: Rm. Mader et al., STEREOSPECIFIC PHARMACOKINETICS OF RAC-5-METHYLTETRAHYDROFOLIC ACID IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, British journal of clinical pharmacology, 40(3), 1995, pp. 209-215
Authors:
LOCKER GJ
SIMONITSCH I
MADER RM
WARLAMIDES E
GNANT MFX
JAKESZ R
RAINER H
STEGER GG
Citation: Gj. Locker et al., CUTANEOUS SIDE-EFFECTS IN BREAST-CANCER PATIENTS TREATED WITH CYTOSTATIC POLYCHEMOTHERAPY AND RH GM-CSF - IMMUNE PHENOMENA OR DRUG TOXICITY, Breast cancer research and treatment, 34(3), 1995, pp. 213-219
Authors:
LOCKER GJ
MADER RM
BRAUN J
SIEDER AE
MAROSI C
RAINER H
JAKESZ R
STEGER GG
Citation: Gj. Locker et al., NEW MUCIN-LIKE CANCER-ASSOCIATED ANTIGENS (CA-M-26, CA-M-29 AND CA-549) AND A NEW PROLIFERATION MARKER (TPS) IN PATIENTS WITH PRIMARY OR ADVANCED BREAST-CANCER, Oncology, 52(2), 1995, pp. 140-144
Authors:
MADER RM
STEGER GG
BRAUN J
RAINER H
Citation: Rm. Mader et al., COMPARISON OF AN IMMUNORADIOMETRIC AND AN IMMUNOLUMINOMETRIC ASSAY FOR THE EVALUATION OF THE TUMOR-ASSOCIATED ANTIGENS CA-19-9 AND CA-125, European journal of clinical chemistry and clinical biochemistry, 32(2), 1994, pp. 85-90
Authors:
MADER RM
RAINER H
STEGER GG
Citation: Rm. Mader et al., BIOCHEMICAL MODULATION OF FLUOROPYRIMIDINES - PRECLINICAL AND CLINICAL-STUDIES, Onkologie, 17(4), 1994, pp. 368-375
Authors:
MADER RM
STEGER GG
RIZOVSKI B
SIEDER AE
LOCKER G
GNANT MFX
JAKESZ R
RAINER H
Citation: Rm. Mader et al., PHARMACOKINETICS OF RAC-LEUCOVORIN VS [S]-LEUCOVORIN IN PATIENTS WITHADVANCED GASTROINTESTINAL CANCER, British journal of clinical pharmacology, 37(3), 1994, pp. 243-248
Authors:
STEGER GG
MADER RM
DJAVANMARD MP
GNANT MFX
LOCKER G
MAROSI C
RAINER H
JAKESZ R
Citation: Gg. Steger et al., DOUBLE-MODULATION OF 5-FLUOROURACIL BY HIGH-DOSE LEUCOVORIN AND INTERFERON-ALPHA-2B IN ADVANCED COLORECTAL-CANCER - A PHASE-I AND A PHASE-II STUDY OF WEEKLY ADMINISTRATION, Journal of cancer research and clinical oncology, 120(5), 1994, pp. 314-318
Authors:
MADER RM
STEGER GG
RIZOVSKI B
JAKESZ R
RAINER H
Citation: Rm. Mader et al., DIFFERENT STEREOSPECIFIC PROTEIN-BINDING OF TETRAHYDROFOLATES TO HUMAN SERUM-ALBUMIN, Journal of pharmaceutical sciences, 83(9), 1994, pp. 1247-1249
Authors:
STEGER GG
MADER RM
VOGELSANG H
SCHOFL R
LOCHS H
FERENCI P
Citation: Gg. Steger et al., FOLATE ABSORPTION IN CROHNS-DISEASE, Digestion, 55(4), 1994, pp. 234-238
Authors:
STEGER GG
MADER RM
GNANT MFX
MAROSI C
LENZ K
JAKESZ R
Citation: Gg. Steger et al., GM-CSF IN THE TREATMENT OF A PATIENT WITH SEVERE METHOTREXATE INTOXICATION, Journal of internal medicine, 233(6), 1993, pp. 499-502
Risultati:
1-19
|